Psilocybin
Silo Wellness Buys NUGL In Deal Valued at C$43 Million
Silo Wellness, Inc. (CSE: SILO) (OTCQB: SILFF) is buying NUGL Inc. (OTC Pink: NUGL) in a deal valued at C$43 million. Last month Silo announced it was…
Silo Wellness, Inc. (CSE: SILO) (OTCQB: SILFF) is buying NUGL Inc. (OTC Pink: NUGL) in a deal valued at C$43 million. Last month Silo announced it was partnering with Jamaica-based Kaya Group, which is owned by Nugl. Nugl and Kaya merged in April 2022 to form a multifaceted cannabis lifestyle company.
The company operates three Kaya Herb House retail locations and a Gap Café wellness center, which would partner well with Silo’s expertise in managing psilocybin wellness retreats in Jamaica’s legal psilocybin market. At the time of that announcement, Silo acquired just over 25 million shares of Nugl. Now the company has decided to buy the remaining shares.
Nugl Revenue
Silo also noted that NUGL/Kaya had top-line revenue of $2.2 million in 2022 along with $1.5 million in gross profit and a $2. million net loss. This was an increase in revenue from $1.8 million in 2021. The company reported revenue in its most recent quarter ending in June of $708,796.
Still, Nugl was reported as a “going concern.” The company has experienced recurring net losses and negative cash flows from operations since inception and as of June 30, 2023, has an accumulated deficit of approximately $7,877,396 (December 31, 2022 – $7,769,953) and a working capital deficit of approximately $610,739 (December 31, 2022 – $753,675). As of June 30, 2023, the company had $75,168 (December 31, 2022 – $86,575) in cash and cash equivalents with a working capital deficit of $610,739.
Partnership Plans
At the time, Silo Wellness said its partnership with NUGL/Kaya Group would bring even more opportunity for expansion and solidifies the company’s presence in Jamaica, a region championing the burgeoning psychedelics industry.
Mike Arnold, founder and CEO of Silo Wellness and an Oregon attorney said “Our collaboration with Kaya is a monumental stride in realizing our vision to offer holistic treatments that combine the best of and broaden our international footprint. We’re committed to providing transformative plant medicine wellness experiences.”
The post Silo Wellness Buys NUGL In Deal Valued at C$43 Million appeared first on Green Market Report.
psilocybin psychedelics silo
-
Psychedelics1 week agoRevive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study of Bucillamine to Treat Long COVID
-
Psychedelics1 week agoAlgernon NeuroScience and the Centre for Human Drug Research to Present DMT Phase 1 Stroke Clinical Data at the Interdisciplinary Conference on Psychedelic Research June 6 – 8th, 2024
-
Law & Regulation1 week agoTryp Therapeutics merger with Exopharm approved by shareholders
-
Psilocybin1 week agoPassover Perspectives: Psychedelics, Moses, and the Burning Bush
-
Psychedelics1 week agoatai Life Sciences Announces Dosing of First Patient in Part 2 of Beckley Psytech’s Phase 2a Study Exploring BPL-003 Adjunctive to SSRIs in Patients with Treatment Resistant Depression
-
Psychedelics1 week agoSilo Pharma Announces Positive Results for Intranasal PTSD Treatment
-
Psilocybin1 week agoPsilocybin and Meditation: Unlocking the Potential for Enhancing Insightfulness
-
Psychedelics1 week ago
Silo Pharma Announces Positive Results for Intranasal PTSD Treatment